Replimune (REPL) stock plunges as the company seeks layoffs following the FDA rejection of its cancer drug RP1 for melanoma.

Top Stories of The WeekBitcoin can be made quantum-safe without protocol upgrade: ResearcherA Bitcoin researcher has come up ...

Oops. A 60MB source map file just leaked Anthropic's entire roadmap.

Kyran Lofthouse scores the winner as Burton claim a vital victory over AFC Wimbledon as the battle for League One safety ...

Rich men, florals, and nearly nekkid Jack Innanen — need we say more?!

Paris Fury has always been as real as it gets – and this time she’s not holding back when it comes to critics of her daughter ...